COVID-19 Tied to Small TSH Shifts in Primary Care Study

Published September 15, 2026, after a Healthcare study reported thyroid-function measurements from a Warsaw primary care cohort.

A retrospective study of 373 adult outpatients found a small difference in average thyroid-stimulating hormone, or TSH, after COVID-19. Average free T3 and free T4 levels stayed about the same. The study describes an association in one clinic population. It does not show that COVID-19 caused the TSH difference or created new thyroid disease.

What the researchers compared

The researchers screened 1,210 adults who received continuing care at a family medicine clinic in Warsaw from January 2022 through December 2024. The final analysis included 373 patients with confirmed COVID-19, thyroid-function results in the study windows, and no previously diagnosed thyroid disease. People with a history of thyroid removal were also excluded.

The group was older and mostly female. Women accounted for 267 participants, or 71.6%. The mean age was 63.8 years and the median age was 66. The researchers compared TSH, free T3, and free T4 results obtained within three months before infection with results obtained within three months afterward. The pre-infection results came from routine care rather than tests ordered for the study.

What changed

Mean TSH was 2.39 mIU/L before infection and 2.17 mIU/L afterward. The authors reported the mean difference as statistically significant at p < 0.05. Mean free T3 was 2.93 before and 2.98 pg/mL after infection. Mean free T4 was 1.31 before and 1.30 ng/dL after infection. Neither peripheral thyroid-hormone measure changed significantly.

There is an important wrinkle in the TSH data. Median TSH moved slightly in the opposite direction, from 1.85 before infection to 1.92 mIU/L afterward. The authors said that difference between the mean and median could reflect an uneven distribution of values and called for caution in interpreting the result. They described the overall thyroid changes as mostly subclinical and said the clinical significance of the small TSH difference remains uncertain.

Where TSH and free T4 fit

TSH is made by the pituitary gland and signals the thyroid to produce T4 and T3. The National Institute of Diabetes and Digestive and Kidney Diseases says clinicians usually check TSH first when evaluating thyroid function. An abnormal TSH result may lead to additional testing to investigate the cause. Free T4 measures the portion of thyroxine that is not bound to proteins in the blood.

LabTestSuperstore has separate pages explaining the TSH test and free T4 test. Those pages describe what each test measures. The new study does not show that people should order either test solely because they previously had COVID-19, and it does not supply a treatment or testing-frequency rule.

Why the result needs restraint

This was a retrospective study from one clinic and it had no non-COVID control group. The researchers could not rule out ordinary biological variation, timing differences, unrelated illness, or regression to the mean. The analysis also lacked consistent information on factors such as body mass index, smoking, other medical conditions, medications, COVID-19 severity, vaccination history, and treatment. It did not adjust for potential confounders with a multivariable model.

The paper reports no effect-size estimate or 95% confidence interval for the TSH change. It also does not establish whether the small average difference persisted over time. Selection depended on having thyroid results in both study windows, which may make the analyzed group different from the wider primary care population. The older, mostly female cohort further limits how broadly the result can be generalized.

The defensible takeaway is narrow: average TSH differed slightly after COVID-19 in this selected primary care cohort, while average free T3 and free T4 did not. The result is descriptive and hypothesis-generating, not proof of causation, a diagnosis, or a reason to change medication or testing on its own.

This article is editorial commentary and is not medical advice. It has not been reviewed by a physician and should not be used to diagnose thyroid disease or make individual decisions about testing, medication, or treatment.